Sinovac Biotech's COVID-19 vaccine enters phase 3 trial globally

The COVID-19 vaccine produced by China's Sinovac Biotech has entered phase 3 trial globally. Helen Yang from the company says the clinical trial will be completed by the end of the year and, after approval, the vaccine will be available in the market soon at an affordable price.